With a weight-loss pill on the horizon and the FDA’s signal of a tougher stance on compounded knockoffs, Novo Nordisk might ...

A large clinical trial found that a daily semaglutide pill produced significant weight loss and health benefits comparable to injectable versions, setting the stage for possible FDA approval later ...

Semaglutide is currently administered through a weekly dose of up to 2.4 milligrams injected into the layer of fat over the ...

GLP-1 medications like Ozempic show promise for multiple health conditions, as experts explore microdosing benefits for blood ...

And it’s not just vanity on the line. Being overweight or obese increases your risk for a laundry list of serious health problems, including Type 2 diabetes, heart disease, stroke, high blood pressure ...

Novo Nordisk A/S rose the most in a month after its diabetes blockbuster Ozempic beat Eli Lilly & Co.’s older drug Trulicity ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.

Novo Nordisk (NVO) shares rose 6% premarket on Thursday after a real-world study showed its diabetes drug Ozempic ...

Duke University scientists have discovered that pancreatic alpha cells, long believed to only produce glucagon, actually ...

Chrissy Teigen opened up about using Ozempic, the GLP-1 medication typically given to diabetes patients to help manage their ...

Kathy Bates has opened up about her health journey, including surviving cancer and losing 100 pounds over six to seven years.

Chrissy Teigen shared that she turned to Ozempic to help her to lose the weight she gained while carrying her and John Legend ...